Verified publication
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients
An ex vivo analysis of inflammatory signaling in blood cells from people with COVID-19, including CD8-positive T-cell responses.
Indexed abstract extractedQuality: LowLow confidence
Study metadata
- Journal
- Open Forum Infectious Diseases
- Publication year
- 2021
- Study type
- In vitro study
- Species
- Human
- Evidence grade
- Grade C
- Extraction depth
- Indexed abstract extracted
- Study quality
- Low
- Confidence
- Low confidence
- Sample size
- Not stated in indexed abstract
Structured extraction
- Population
- Human participants; population details require article-level extraction.
- Intervention
- In vitro exposure details require abstract or full-text extraction before use.
- Comparator
- Not stated or not fully extracted from the indexed abstract.
- Duration
- Not stated or not fully extracted from the indexed abstract.
- Primary endpoint
- Primary assay endpoint not fully extracted.
- Secondary endpoints
- No secondary endpoints extracted.
- Funding source
- Not stated in the indexed abstract.
Findings and extraction notes
- The abstract reports reduced cytokine expression and lymphocyte activation after ex vivo thymosin alpha-1 exposure.
Limitations
- Ex vivo blood-cell responses do not establish an in vivo treatment effect.
- The indexed abstract does not state the number of donors or samples.